OREXIGEN THERAPEUTIC OREX (NASDAQ)

$ 11.66
16:19
Change: +0.21 (+1.83%)
Volume: 316,785

Avg. Volume: 160939
P/E Ratio: 0
EPS (Annual): -2.66
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 34,310
Institutional Shareholders: 47.40%
Last: 11.66
Change: +0.21 (+1.83%)
Prev. Close: 11.45
Open: 11.37
Day's Range: 10.54 - 12.00
52wk Range: 6.89 - 18.45
Market Value: 361,270
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -18.33%
Total Return Last 3 Years: -11.06%
Total Return Last 5 Years: -11.92%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on OREX

Earnings roundup: Dionex, Kite Realty

Among the earnings stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Dionex Corp. fell sharply Friday after the laboratory equipment maker reported bette...READ MORE
Aug 08, 2008 3:06PM
Keywords: DNEX, KRG, NCTY, UFS, WCRX, OREX

Greater research costs widen Orexigen 2Q loss

(SAN DIEGO)Obesity drug developer Orexigen Therapeutics Inc. said its second-quarter loss nearly doubled from last year as it continued testing its drug candidates.READ MORE
Aug 08, 2008 11:54AM
Keywords: OREX

Orexigen wins patent covering lead obesity drug

(SAN DIEGO)Obesity drug developer Orexigen Therapeutics Inc. said Tuesday the U.S. Patent and Trademark Office issued a patent covering its lead candidate. The drug candidate, Contrave, is in...READ MORE
May 27, 2008 10:08AM
Keywords: OREX

Market Spotlight: Obesity Drug Makers

(NEW YORK)The race for a magic weight-loss pill will heat up in 2008, with several major pharmaceutical companies expected to release key clinical trial data on drugs that appear to generate...READ MORE
Jan 03, 2008 2:25PM
Keywords: AMLN, ABT, PFE, OREX, MRK, ARNA, VVUS, ATHX, GSK, BMY, NVO
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +40.60 63.57
GILEAD SCIENCES +40.80 54.62
BIOGEN IDEC INC -5.30 54.10
GENENTECH INC +44.80 97.99
CELGENE CP +26.60 72.34